Enhancement of ketoconazole dissolution rate by the liquisolid technique

1. M. Wesoły, K. Cal, P. Ciosek and W. Wróblewski, Influence of dissolution-modifying excipients in various pharmaceutical formulations on electronic tongue results, Talanta162 (2017) 203–209; https://doi.org/10.1016/j.talanta.2016.10.01810.1016/j.talanta.2016.10.018Search in Google Scholar

2. A. Nokhodchi, C. M. Hentzschel and C. S. Leopold, Drug release from liquisolid systems: speed it up, slow it down, Expert Opin. Drug Deliv.8 (2011) 191–205; https://doi.org/10.1517/17425247.2011.54880110.1517/17425247.2011.548801Search in Google Scholar

3. L. Azharshekoufeh, J. Shokri, M. B. Jalali and Y. Javadzadeh, Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies, BioImpacts7 (2017) 5–12; https://doi.org/10.15171/bi.2017.0210.15171/bi.2017.02Search in Google Scholar

4. A. B. Karmarkar, I. D. Gonjar and A. H. Hosmani, Liquisolid technology for dissolution rate enhancement or sustained release, Expert Opin. Drug Deliv.7 (2010) 1227–1234; https://doi.org/10.1517/17425247.2010.51117310.1517/17425247.2010.511173Search in Google Scholar

5. I. Theochari, M. Goulielmaki, D. Danino, V. Papadimitriou, A. Pintzas and A. Xenakis, Drug nanocarriers for cancer chemotherapy based on microemulsions: the case of Vemurafenib analog PLX4720, Colloids Surf. B Biointerfaces154 (2017) 350–356; https://doi.org/10.1016/j.colsurfb.2017.03.03210.1016/j.colsurfb.2017.03.032Search in Google Scholar

6. M. Colombo, S. Staufenbiel, E. Rühl and R. Bodmeier, In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application, Int. J. Pharm.521 (2017) 156–166; https://doi.org/10.1016/j.ijpharm.2017.02.03010.1016/j.ijpharm.2017.02.030Search in Google Scholar

7. K. Sigfridsson, P. Skantze, U. Skantze, L. Svensson, L. Löfgren, P. Nordell, E. Michaëlsson, B. Smedsrød, B. Fuglesteg and K. Elvevold, Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice, Int. J. Pharm.524 (2017) 248–256; https://doi.org/10.1016/j.ijpharm.2017.03.06210.1016/j.ijpharm.2017.03.062Search in Google Scholar

8. R. Ghanavati, A. Taheri and A. Homayouni, Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier, Mater. Sci. Eng. C72 (2017) 501–511; https://doi.org/10.1016/j.msec.2016.11.04210.1016/j.msec.2016.11.042Search in Google Scholar

9. K. I. Shingel, M. Selyanin, M. C. Filion and F. Polyak, Solid dispersions of drugs in hyaluronan matrix: The role of the biopolymer in modulating drug activity in vivo, J. Drug Deliv. Sci. Technol.39 (2017) 140–146; https://doi.org/10.1016/j.jddst.2017.03.01810.1016/j.jddst.2017.03.018Search in Google Scholar

10. P. Veres, M. Kéri, I. Bányai, I. Lázár, I. Fábián, C. Domingo and J. Kalmár, Mechanism of drug release from silica-gelatin aerogel. Relationship between matrix structure and release kinetics, Colloids Surf. B Biointerfaces152 (2017) 229–237; https://doi.org/10.1016/j.colsurfb.2017.01.01910.1016/j.colsurfb.2017.01.019Search in Google Scholar

11. M. Lu, H. Xing, T. Yang, J. Yu, Z. Yang, Y. Sun and P. Ding, Dissolution enhancement of tadalafil by liquisolid technique, Pharm. Dev. Technol.22 (2017) 77–89; https://doi.org/10.1080/10837450.2016.118956310.1080/10837450.2016.1189563Search in Google Scholar

12. K. T. Savjani, A. K. Gajjar, J and K. Savjani, Drug solubility: Importance and enhancement techniques, ISRN Pharm.2012 (2012) 1–10; https://doi.org/10.5402/2012/19572710.5402/2012/195727Search in Google Scholar

13. T. L. Rogers, K. A. Overhoff, P. Shah, P. Santiago, M. J. Yacaman, K. P. Johnston and R. O. Williams, Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process, Eur. J. Pharm. Biopharm.55 (2003) 161–172; https://doi.org/10.1016/S0939-6411(02)00193-510.1016/S0939-6411(02)00193-5Search in Google Scholar

14. Y. Javadzadeh, B. Jafari-Navimipour and A. Nokhodchi, Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine), Int. J. Pharm.341 (2007) 26–34; https://doi.org/10.1016/j.ijpharm.2007.03.03410.1016/j.ijpharm.2007.03.034Search in Google Scholar

15. Y. Javadzadeh, M. R. Siahi, S. Asnaashari and A. Nokhodchi, Liquisolid technique as a tool for the enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties, Acta Pharm.57 (2007) 99–109; https://doi.org/10.2478/v10007-007-0008-610.2478/v10007-007-0008-6Search in Google Scholar

16. Y. Javadzadeh, M. Siahi-Shadbad, M. Barzegar-Jalali and A. Nokhodchi, Enhancement of dissolution rate of piroxicam using liquisolid compacts, Il Farmaco60 (2005) 361–365; https://doi.org/10.1016/j.farmac.2004.09.00510.1016/j.farmac.2004.09.005Search in Google Scholar

17. V. De Campos, C. Cerqueira-Coutinho, F. Capella, B. Soares, C. Holandino and C. Mansur, Development and in vitro assessment of nanoemulsion for delivery of ketoconazole against Candida albicans, J. Nanosci. Nanotechnol.17 (2017) 4623–4630; https://doi.org/10.1166/jnn.2017.1344510.1166/jnn.2017.13445Search in Google Scholar

18. P. Deng, F. Teng, F. Zhou, Z. Song, N. Meng and R. Feng, Methoxy poly (ethylene glycol)-b-poly (δ-valerolactone) copolymeric micelles for improved skin delivery of ketoconazole, J. Biomater. Sci. Polym. Ed.28 (2017) 63–78; https://doi.org/10.1080/09205063.2016.124437110.1080/09205063.2016.1244371Search in Google Scholar

19. G. A. Abdelbary, M. M. Amin and M. Y. Zakaria, Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies, Drug Deliv.24 (2017) 309–319; https://doi.org/10.1080/10717544.2016.124792810.1080/10717544.2016.1247928Search in Google Scholar

20. A. M. Stewart, M. E. Grass, D. M. Mudie, M. M. Morgen, D. T. Friesen and D. T. Vodak, Development of a biorelevant, material-sparing membrane flux test for rapid screening of bioavailability-enhancing drug product formulations, Mol. Pharm.14 (2017) 2032–2046; https://doi.org/10.1021/acs.molpharmaceut.7b0012110.1021/acs.molpharmaceut.7b00121Search in Google Scholar

21. J. Bassi da Silva, S. B. d. S. Ferreira, O. de Freitas and M. L. Bruschi, A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems, Drug Dev. Ind. Pharm.43 (2017) 1053–1070; https://doi.org/10.1080/03639045.2017.129460010.1080/03639045.2017.1294600Search in Google Scholar

22. A. Ruff, T. Fiolka and E. S. Kostewicz, Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling, Eur. J. Pharm. Sci.100 (2017) 42–55; https://doi.org/10.1016/j.ejps.2016.12.01710.1016/j.ejps.2016.12.017Search in Google Scholar

23. Y. Tsume, K. Matsui, A. L. Searls, S. Takeuchi, G. E. Amidon, D. Sun and G. L. Amidon, The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS), Eur. J. Pharm. Sci.102 (2017) 126–139; https://doi.org/10.1016/j.ejps.2017.02.04210.1016/j.ejps.2017.02.042Search in Google Scholar

24. T. Loftsson and E. Stefánsson, Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye, Int. J. Pharm.531 (2017) 413–423; https://doi.org/10.1016/j.ijpharm.2017.04.01010.1016/j.ijpharm.2017.04.010Search in Google Scholar

25. G. Balata, M. Mahdi and R. A. Bakera, Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes, Indian J. Pharm. Sci.5 (2011) 517–526; https://doi.org/10.4103/0250-474X.9899510.4103/0250-474X.98995Search in Google Scholar

26. K. Inaba, T. Wakuda and K. Uekama, Prostaglandins and their cyclodextrin complexes, J. Incl. Phenom. Macrocycl. Chem.2 (1984) 467–474; https://doi.org/10.1007/BF0066221310.1007/BF00662213Search in Google Scholar

27. P. Kanaujia, G. Lau, W. K. Ng, E. Widjaja, M. Schreyer, A. Hanefeld, M. Fischbach, C. Saal, M. Maio and R. B. Tan, Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy, Drug Dev. Ind. Pharm.37 (2011) 1026–1035; https://doi.org/10.3109/03639045.2011.55809110.3109/03639045.2011.558091Search in Google Scholar

28. A. Gryczke, S. Schminke, M. Maniruzzaman, J. Beck and D. Douroumis, Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion, Colloids Surf. B Biointerfaces.86 (2011) 275–284; https://doi.org/10.1016/j.colsurfb.2011.04.00710.1016/j.colsurfb.2011.04.007Search in Google Scholar

29. M. Dhanaraju, K. S. Kumaran, T. Baskaran and M. S. R. Moorthy, Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin, Drug Dev. Ind. Pharm.24 (1998) 583–587; https://doi.org/10.3109/0363904980908566310.3109/03639049809085663Search in Google Scholar

30. Y. Javadzadeh, M. R. Siahi, S. Asnaashari and A. Nokhodchi, An investigation of physicochemical properties of piroxicam liquisolid compacts, Pharm. Dev. Technol.12 (2007) 337–343; https://doi.org/10.1080/1083745070124757410.1080/10837450701247574Search in Google Scholar